Literature DB >> 20002100

Arachidonic acid release mediated by OX1 orexin receptors.

Pauli M Turunen1, Marie E Ekholm, Pentti Somerharju, Jyrki P Kukkonen.   

Abstract

BACKGROUND AND
PURPOSE: We have previously shown that lipid mediators, produced by phospholipase D and C, are generated in OX(1) orexin receptor signalling with high potency, and presumably mediate some of the physiological responses to orexin. In this study, we investigated whether the ubiquitous phospholipase A(2) (PLA(2)) signalling system is also involved in orexin receptor signalling. EXPERIMENTAL APPROACH: Recombinant Chinese hamster ovary-K1 cells, expressing human OX(1) receptors, were used as a model system. Arachidonic acid (AA) release was measured from (3)H-AA-labelled cells. Ca(2+) signalling was assessed using single-cell imaging. KEY
RESULTS: Orexins strongly stimulated [(3)H]-AA release (maximally 4.4-fold). Orexin-A was somewhat more potent than orexin-B (pEC(50) = 8.90 and 8.38 respectively). The concentration-response curves appeared biphasic. The release was fully inhibited by the potent cPLA(2) and iPLA(2) inhibitor, methyl arachidonyl fluorophosphonate, whereas the iPLA(2) inhibitors, R- and S-bromoenol lactone, caused only a partial inhibition. The response was also fully dependent on Ca(2+) influx, and the inhibitor studies suggested involvement of the receptor-operated influx pathway. The receptor-operated pathway, on the other hand, was partially dependent on PLA(2) activity. The extracellular signal-regulated kinase, but not protein kinase C, were involved in the PLA(2) activation at low orexin concentrations. CONCLUSIONS AND IMPLICATIONS: Activation of OX(1) orexin receptors induced a strong, high-potency AA release, possibly via multiple PLA(2) species, and this response may be important for the receptor-operated Ca(2+) influx. The response coincided with other high-potency lipid messenger responses, and may interact with these signals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20002100      PMCID: PMC2823366          DOI: 10.1111/j.1476-5381.2009.00535.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

Review 1.  ARC channels: a novel pathway for receptor-activated calcium entry.

Authors:  Trevor J Shuttleworth; Jill L Thompson; Olivier Mignen
Journal:  Physiology (Bethesda)       Date:  2004-12

2.  OX1 orexin receptors couple to adenylyl cyclase regulation via multiple mechanisms.

Authors:  Tomas Holmqvist; Lisa Johansson; Marie Ostman; Sylwia Ammoun; Karl E O Akerman; Jyrki P Kukkonen
Journal:  J Biol Chem       Date:  2004-12-16       Impact factor: 5.157

3.  Isoprenylated human brain type I inositol 1,4,5-trisphosphate 5-phosphatase controls Ca2+ oscillations induced by ATP in Chinese hamster ovary cells.

Authors:  F De Smedt; L Missiaen; J B Parys; V Vanweyenberg; H De Smedt; C Erneux
Journal:  J Biol Chem       Date:  1997-07-11       Impact factor: 5.157

Review 4.  The TRP superfamily of cation channels.

Authors:  Craig Montell
Journal:  Sci STKE       Date:  2005-02-22

Review 5.  Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.

Authors:  T Kenakin
Journal:  Trends Pharmacol Sci       Date:  1995-07       Impact factor: 14.819

6.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.

Authors:  T Sakurai; A Amemiya; M Ishii; I Matsuzaki; R M Chemelli; H Tanaka; S C Williams; J A Richardson; G P Kozlowski; S Wilson; J R Arch; R E Buckingham; A C Haynes; S A Carr; R S Annan; D E McNulty; W S Liu; J A Terrett; N A Elshourbagy; D J Bergsma; M Yanagisawa
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

7.  Orexin-A-induced Ca2+ entry: evidence for involvement of trpc channels and protein kinase C regulation.

Authors:  Kim P Larsson; Hanna M Peltonen; Genevieve Bart; Lauri M Louhivuori; Annika Penttonen; Miia Antikainen; Jyrki P Kukkonen; Karl E O Akerman
Journal:  J Biol Chem       Date:  2004-11-10       Impact factor: 5.157

8.  Arachidonic acid release from mammalian cells transfected with human groups IIA and X secreted phospholipase A(2) occurs predominantly during the secretory process and with the involvement of cytosolic phospholipase A(2)-alpha.

Authors:  Carine M Mounier; Farideh Ghomashchi; Margaret R Lindsay; Scott James; Alan G Singer; Robert G Parton; Michael H Gelb
Journal:  J Biol Chem       Date:  2004-03-08       Impact factor: 5.157

9.  Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities.

Authors:  Christopher M Jenkins; David J Mancuso; Wei Yan; Harold F Sims; Beverly Gibson; Richard W Gross
Journal:  J Biol Chem       Date:  2004-09-10       Impact factor: 5.157

Review 10.  Regulation of the specific release of arachidonic acid by cytosolic phospholipase A2.

Authors:  Christina C Leslie
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2004-04       Impact factor: 4.006

View more
  6 in total

1.  Orexin/hypocretin receptor signalling: a functional perspective.

Authors:  C S Leonard; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 2.  Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA?

Authors:  Shaun Yon-Seng Khoo; Robyn Mary Brown
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

3.  OX1 orexin/hypocretin receptor activation of phospholipase D.

Authors:  M H Jäntti; J Putula; P Somerharju; M A Frohman; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 4.  Orexin/hypocretin receptor signalling cascades.

Authors:  J P Kukkonen; C S Leonard
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

5.  Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytes.

Authors:  M Skrzypski; T T Le; P Kaczmarek; E Pruszynska-Oszmalek; P Pietrzak; D Szczepankiewicz; P A Kolodziejski; M Sassek; A Arafat; B Wiedenmann; K W Nowak; M Z Strowski
Journal:  Diabetologia       Date:  2011-04-21       Impact factor: 10.122

6.  Orexin receptors in GtoPdb v.2021.3.

Authors:  Paul Coleman; Luis de Lecea; Anthony Gotter; Jim Hagan; Daniel Hoyer; Thomas Kilduff; Jyrki P Kukkonen; Rod Porter; John Renger; Jerome M Siegel; Gregor Sutcliffe; Neil Upton; Christopher J Winrow
Journal:  IUPHAR BPS Guide Pharm CITE       Date:  2021-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.